Authors: Campbell, NRC Carruthers, SG Wilson, E Nagpal, S Chockalingam, A Squires, T Levine, M Zarnke, K McAlister, F Abbott, C Mann, K Bolli, P McKay, D Myers, M Wilson, T Honos, G Burgess, E Petrella, R Touyz, R Lewanczuk, R Wright, J Culleton, B Leenen, F Rabkin, S Stone, J Fodor, G Hamet, P Herman, R Lebel, M Burgess, E Tobe, S Feldman, RD Irvine, J Eady, A Nagpai, S Campbell, N Milot, A Chockalingam, A Ebenhoeh, H Drouin, D Feldman, R Repchinsky, C Ruddy, T Stewart, P Tremblay, G Wilson, E

Citation: Nrc. Campbell et al., The 2000 Canadian hypertension recommendations: A summary, CAN J CARD, 17(5), 2001, pp. 535-538

Authors: McAlister, FA Levine, M Zarnke, KB Campbell, N Lewanczuk, R Leenen, F Rabkin, S Wright, JM Stone, J Feldman, RD Lebel, M Honos, G Fodor, G Burgess, E Tobe, S Hamet, P Herman, R Irvine, J Culleton, B Petrella, R Touyz, R

Citation: Fa. Mcalister et al., The 2000 Canadian recommendations for the management of hypertension: Partone - therapy, CAN J CARD, 17(5), 2001, pp. 543-559

Authors: McLaughlin, K Manns, B Culleton, B Donaldson, C Taub, K

Citation: K. Mclaughlin et al., An economic evaluation of early versus late referral of patients with progressive renal insufficiency, AM J KIDNEY, 38(5), 2001, pp. 1122-1128

Authors: Culleton, B Levy, D

Citation: B. Culleton et D. Levy, Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease - Response, HYPERTENSIO, 35(3), 2000, pp. E105-E108

Authors: Bostom, AG Culleton, B

Citation: Ag. Bostom et B. Culleton, Hyperhomocysteinemia in chronic renal disease: Potential relevance to arteriosclerosis, SEMIN DIAL, 12(2), 1999, pp. 103-111

Authors: Kelly, DP Culleton, B

Citation: Dp. Kelly et B. Culleton, Process improvement for small organizations, COMPUTER, 32(10), 1999, pp. 41